Document Detail


Poor to modest agreement between rheumatoid arthritis response measures in clinical practice.
MedLine Citation:
PMID:  19772796     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To evaluate the agreement among several rheumatoid arthritis (RA) response measures in a clinical setting. METHODS: 529 patients with RA were seen at 2 regular visits where the following response measures were determined: ACR-20, EULAR good or moderate (EULAR-GM), Simplified Disease Activity Index moderate (SDAI-M), Clinical DAI moderate (CDAI-M), and Patient Reported Outcomes Index-M 20 (PRO-IM-20). Each measure was modified to include a "worse" response, i.e. the inverse of the respective guidelines for a positive improvement response.Introduced for comparison was the Real-time Assessment of Disease Activity in Rheumatoid Arthritis (RADARA), a response measure that registers improvement if the patient's tender and swollen joint counts and HAQ score all improve and worsening if all three increase. Contingency tables comparing the three responses (worse, no change, and improvement) along with Cohen's kappa were calculated. RESULTS: The mean (SD) baseline characteristics of the patients included: age 66.5 (10.7) years, RA duration 12.9 (11.0) years, 91.3% male, 84.1% rheumatoid factor positive, and a Disease Activity Score-28 of 3.5 (1.3). The percentage of patients who improved/worsened were as follows: ACR-20 4.7/9.1, EULAR-GM 23.4/26.3, SDAI-M 16.1/20.6, CDAI-M 16.3/20.0, PRO-IM-20 22.5/34.4, and RADARA 7.0/11.5. Agreement (kappa) was poor to slight (</= 0.4) between most of the response measures with the exception of RADARA/ACR-20 which showed substantial agreement (0.67) and SDAI/EULAR-GM and CDAI/EULAR-GM, which showed moderate agreement (0.54 and 0.52, respectively). CONCLUSION: RA response measures can be made more informative by the addition of a "worse" response, although even in this case the agreement in the clinic setting is primarily poor to moderate.
Authors:
K Michaud; T R Mikuls; S E Call; A M Reimold; R Hooker; G S Kerr; J S Richards; L Caplan; G W Cannon
Related Documents :
24577466 - Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impair...
15050886 - Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the l...
11752506 - Soluble hla class i antigens in serum and synovial fluid from patients with rheumatoid ...
2357496 - Increased apotranscobalamin ii levels in rheumatoid arthritis.
3414926 - Postoperative sore throat related to the use of a guedel airway.
3819126 - Computed tomography of hepatic fascioliasis.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Clinical and experimental rheumatology     Volume:  27     ISSN:  0392-856X     ISO Abbreviation:  Clin. Exp. Rheumatol.     Publication Date:    2009 Jul-Aug
Date Detail:
Created Date:  2009-09-23     Completed Date:  2009-11-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8308521     Medline TA:  Clin Exp Rheumatol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  633-40     Citation Subset:  IM    
Affiliation:
VA Medical Center and Nebraska Arthritis Outcomes Research Center, University of Nebraska Medical Center, Omaha, Nebraska, USA. kmichaud@unmc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Antirheumatic Agents / therapeutic use
Arthritis, Rheumatoid / diagnosis,  drug therapy,  physiopathology*
Disability Evaluation
Disease Progression
Female
Health Status
Hospitals, Veterans
Humans
Joints / pathology,  physiopathology
Male
Pain / physiopathology
Pain Measurement
Reproducibility of Results
Severity of Illness Index*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antirheumatic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antibodies against recombinant heat shock proteins of 60 kDa from enterobacteria in the sera and syn...
Next Document:  Increased incidence of stroke and impaired prognosis after stroke among patients with seropositive r...